Cargando…
Strategy and rationale for urine collection protocols employed in the NEPTUNE study
BACKGROUND: Glomerular diseases are potentially fatal, requiring aggressive interventions and close monitoring. Urine is a readily-accessible body fluid enriched in molecular signatures from the kidney and therefore particularly suited for routine clinical analysis as well as development of non-inva...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650313/ https://www.ncbi.nlm.nih.gov/pubmed/26577187 http://dx.doi.org/10.1186/s12882-015-0185-3 |
_version_ | 1782401473907261440 |
---|---|
author | Hogan, Marie C. Lieske, John C. Lienczewski, Chrysta C. Nesbitt, Lisa L. Wickman, Larysa T. Heyer, Christina M. Harris, Peter C. Ward, Christopher J. Sundsbak, Jamie L. Manganelli, Luca Ju, Wenjun Kopp, Jeffrey B. Nelson, Peter J. Adler, Sharon G. Reich, Heather N. Holzmann, Lawrence B. Kretzler, Matthias Bitzer, Markus |
author_facet | Hogan, Marie C. Lieske, John C. Lienczewski, Chrysta C. Nesbitt, Lisa L. Wickman, Larysa T. Heyer, Christina M. Harris, Peter C. Ward, Christopher J. Sundsbak, Jamie L. Manganelli, Luca Ju, Wenjun Kopp, Jeffrey B. Nelson, Peter J. Adler, Sharon G. Reich, Heather N. Holzmann, Lawrence B. Kretzler, Matthias Bitzer, Markus |
author_sort | Hogan, Marie C. |
collection | PubMed |
description | BACKGROUND: Glomerular diseases are potentially fatal, requiring aggressive interventions and close monitoring. Urine is a readily-accessible body fluid enriched in molecular signatures from the kidney and therefore particularly suited for routine clinical analysis as well as development of non-invasive biomarkers for glomerular diseases. METHODS: The Nephrotic Syndrome Study Network (NEPTUNE; ClinicalTrials.gov Identifier NCT01209000) is a North American multicenter collaborative consortium established to develop a translational research infrastructure for nephrotic syndrome. This includes standardized urine collections across all participating centers for the purpose of discovering non-invasive biomarkers for patients with nephrotic syndrome due to minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy. Here we describe the organization and methods of urine procurement and banking procedures in NEPTUNE. RESULTS: We discuss the rationale for urine collection and storage conditions, and demonstrate the performance of three experimental analytes (neutrophil gelatinase-associated lipocalin [NGAL], retinol binding globulin, and alpha-1 microglobulin) under these conditions with and without urine preservatives (thymol, toluene, and boric acid). We also demonstrate the quality of RNA and protein collected from the urine cellular pellet and exosomes. CONCLUSIONS: The urine collection protocol in NEPTUNE allows robust detection of a wide range of proteins and RNAs from urine supernatant and pellets collected longitudinally from each patient over 5 years. Combined with the detailed clinical and histopathologic data, this provides a unique resource for exploration and validation of new or accepted markers of glomerular diseases. TRIAL REGISTRATION: ClinicalTrials.gov Identifier NCT01209000 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12882-015-0185-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4650313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46503132015-11-19 Strategy and rationale for urine collection protocols employed in the NEPTUNE study Hogan, Marie C. Lieske, John C. Lienczewski, Chrysta C. Nesbitt, Lisa L. Wickman, Larysa T. Heyer, Christina M. Harris, Peter C. Ward, Christopher J. Sundsbak, Jamie L. Manganelli, Luca Ju, Wenjun Kopp, Jeffrey B. Nelson, Peter J. Adler, Sharon G. Reich, Heather N. Holzmann, Lawrence B. Kretzler, Matthias Bitzer, Markus BMC Nephrol Research Article BACKGROUND: Glomerular diseases are potentially fatal, requiring aggressive interventions and close monitoring. Urine is a readily-accessible body fluid enriched in molecular signatures from the kidney and therefore particularly suited for routine clinical analysis as well as development of non-invasive biomarkers for glomerular diseases. METHODS: The Nephrotic Syndrome Study Network (NEPTUNE; ClinicalTrials.gov Identifier NCT01209000) is a North American multicenter collaborative consortium established to develop a translational research infrastructure for nephrotic syndrome. This includes standardized urine collections across all participating centers for the purpose of discovering non-invasive biomarkers for patients with nephrotic syndrome due to minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy. Here we describe the organization and methods of urine procurement and banking procedures in NEPTUNE. RESULTS: We discuss the rationale for urine collection and storage conditions, and demonstrate the performance of three experimental analytes (neutrophil gelatinase-associated lipocalin [NGAL], retinol binding globulin, and alpha-1 microglobulin) under these conditions with and without urine preservatives (thymol, toluene, and boric acid). We also demonstrate the quality of RNA and protein collected from the urine cellular pellet and exosomes. CONCLUSIONS: The urine collection protocol in NEPTUNE allows robust detection of a wide range of proteins and RNAs from urine supernatant and pellets collected longitudinally from each patient over 5 years. Combined with the detailed clinical and histopathologic data, this provides a unique resource for exploration and validation of new or accepted markers of glomerular diseases. TRIAL REGISTRATION: ClinicalTrials.gov Identifier NCT01209000 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12882-015-0185-3) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-17 /pmc/articles/PMC4650313/ /pubmed/26577187 http://dx.doi.org/10.1186/s12882-015-0185-3 Text en © Hogan et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Hogan, Marie C. Lieske, John C. Lienczewski, Chrysta C. Nesbitt, Lisa L. Wickman, Larysa T. Heyer, Christina M. Harris, Peter C. Ward, Christopher J. Sundsbak, Jamie L. Manganelli, Luca Ju, Wenjun Kopp, Jeffrey B. Nelson, Peter J. Adler, Sharon G. Reich, Heather N. Holzmann, Lawrence B. Kretzler, Matthias Bitzer, Markus Strategy and rationale for urine collection protocols employed in the NEPTUNE study |
title | Strategy and rationale for urine collection protocols employed in the NEPTUNE study |
title_full | Strategy and rationale for urine collection protocols employed in the NEPTUNE study |
title_fullStr | Strategy and rationale for urine collection protocols employed in the NEPTUNE study |
title_full_unstemmed | Strategy and rationale for urine collection protocols employed in the NEPTUNE study |
title_short | Strategy and rationale for urine collection protocols employed in the NEPTUNE study |
title_sort | strategy and rationale for urine collection protocols employed in the neptune study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650313/ https://www.ncbi.nlm.nih.gov/pubmed/26577187 http://dx.doi.org/10.1186/s12882-015-0185-3 |
work_keys_str_mv | AT hoganmariec strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT lieskejohnc strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT lienczewskichrystac strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT nesbittlisal strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT wickmanlarysat strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT heyerchristinam strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT harrispeterc strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT wardchristopherj strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT sundsbakjamiel strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT manganelliluca strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT juwenjun strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT koppjeffreyb strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT nelsonpeterj strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT adlersharong strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT reichheathern strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT holzmannlawrenceb strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT kretzlermatthias strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy AT bitzermarkus strategyandrationaleforurinecollectionprotocolsemployedintheneptunestudy |